Showing results (231-240 of 334) with videos related to

Sort By:
Pageof 34
The Journal of Clinical Investigation|March 8, 2019
Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccinationEléna Gonçalves, Olivia Bonduelle, Angèle Soria, et al.
Human Vaccines|February 18, 2009
Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendationsOdile Launay, Christine Toneatti, Claire Bernède, et al.
Arthritis Care & Research|April 5, 2013
Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort studySolen Kernéis, Odile Launay, Thierry Ancelle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2021
Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?Caroline Papeix, Julie Mazoyer, Elisabeth Maillart, et al.
Diabetes|September 22, 2012
HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexesMatthieu Scotto, Georgia Afonso, Thomas Østerbye, et al.
Frontiers in Immunology|March 26, 2019
Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical TrialOdile Launay, Augustin G W Ndiaye, Valentino Conti, et al.
BMC Medical Education|January 7, 2021
Positive effects of lumbar puncture simulation training for medical students in clinical practiceSinead Gaubert, Alice Blet, Fadia Dib, et al.
The European Respiratory Journal|August 27, 2021
In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019: an observational studyAlexandre Descamps, Nezha Lenzi, Florence Galtier, et al.
BMC Infectious Diseases|September 18, 2013
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trialsOdile Launay, Xavier Duval, Serge Fitoussi, et al.
Vaccine|January 8, 2026
Safety and immunogenicity of BNT162b2 vaccine in children with acute leukaemia: results and perspectives of an open-label, two-centre, phase 1/2 trial with dose finding studyFanny Alby-Laurent, Amani Ouedrani, Pierre Jateau, et al.
Pageof 34